Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT)
The Lancet Global Health2022Vol. 10(9), pp. e1336–e1346
Citations Over TimeTop 10% of 2022 papers
Andrew J B Vallely, Marion Saville, Steven G. Badman, Josephine Gabuzzi, John Bolnga, Glen Mola, Joseph Kuk, Malts Wai, Gloria Munnull, Suzanne M. Garland, Julia Brotherton, Angela Kelly‐Hanku, Chris Morgan, Pamela J Toliman, Zure Kombati, Grace Kariwiga, Delly Babona, Grace Hwei Ching Tan, Kate T. Simms, Alyssa M. Cornall, Sepehr N. Tabrizi, Handan Wand, Rebecca Guy, Karen Canfell, John Kaldor
Abstract
Australian National Health and Medical Research Council.
Related Papers
- → Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis(2021)44 cited
- → Are women sufficiently well informed to provide valid consent for the cervical smear test?(2000)23 cited
- → Colposcopy and cervical intraepithelial neoplasia(2020)3 cited
- Cervical cancer screening. Organised screening to avoid unnecessary conisation.(2010)
- → Colposcopy and Surgical Management of Early Stage Cervical Cancer(2018)